ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
bullish•Alteogen Inc
•31 Jul 2024 07:05

KRX New Deal Index Rebalance Preview: Potential Changes as Review Period Ends Today

We expect at least 1 change for each of the Secondary Battery, Bio, Internet, Game and BBIG indices. Flows are pretty big on some of the stocks and...

Logo
517 Views
Share
•31 Jul 2024 06:00

KRX Short Interest Weekly (Jul 26th): Shinhan Financia, Amorepacific, Kb Financial, Skc, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Shinhan Financia, Amorepacific, Kb Financial,...

Logo
363 Views
Share
•24 Jul 2024 06:00

KRX Short Interest Weekly (Jul 19th): Doosan Enerbility

We analyzed KRX short interest report for the past week and highlighted short interest changes in Doosan Enerbility (034020 KS).

Logo
460 Views
Share
•10 Jul 2024 06:00

KRX Short Interest Weekly (Jul 5th): Hlb, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hlb(028300 KS), Posco(005490 KS).

Logo
355 Views
Share
bullish•Posco Future M
•10 Jul 2024 05:50

KRX New Deal Index Rebalance Preview: Lots of Change; Shift Up Listing Adds to It

There should be 1 change for each of the Battery, Bio and Game indices plus 2 changes for each of the Internet and BBIG indices. The Shift Up...

Logo
694 Views
Share
x